![](/img/cover-not-exists.png)
P-173 * Concomitant statins can be the favorable factor for gemcitabine and erlotinib combination chemotherapy in advanced pancreatic cancer
Lee, H. S., Chung, M. J., Song, S. Y., Bang, S.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.173
Date:
June, 2015
File:
PDF, 30 KB
english, 2015